Publication|Videos|May 2, 2024

Waters Introduces the Next Generation of HPLC for Biopharmaceutical Separations

Sponsored by Waters Corporation

Fraser McLeod sat down with LCGC to discuss the latest HPLC system as well as where Waters is headed for the future.

Learn more about:

  • The Alliance iS Bio HPLC System, the new instrument in the Alliance iS HPLC family, designed for biopharma QC labs.
  • The impact of the new system on biopharma customers, and on the broader biopharma QC market.
  • Where the future of LC is heading at Waters.

Related to this article

Debunking Myths and Half-Truths in HPLC and Pharmaceutical Analysis
"Perspectives in HPLC" examines 5 long-held HPLC "rules" (mobile phase filtration, routine buffer use, avoiding pH near an analyte's pKa, defaulting to 4.6-mm columns, and relying on AI for early method development), showing with experimental evidence that each is conditional rather than universally true in modern small-molecule drug testing.